DK1556703T3 - Inhibitorer af Src-kinase til anvendelse ved alzheimers sygdom - Google Patents

Inhibitorer af Src-kinase til anvendelse ved alzheimers sygdom

Info

Publication number
DK1556703T3
DK1556703T3 DK03776874T DK03776874T DK1556703T3 DK 1556703 T3 DK1556703 T3 DK 1556703T3 DK 03776874 T DK03776874 T DK 03776874T DK 03776874 T DK03776874 T DK 03776874T DK 1556703 T3 DK1556703 T3 DK 1556703T3
Authority
DK
Denmark
Prior art keywords
compound
disease
alzheimer
src
pharmaceutical
Prior art date
Application number
DK03776874T
Other languages
Danish (da)
English (en)
Inventor
Luc Mercken
Nicola Zambrano
Tommaso Russo
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1556703T3 publication Critical patent/DK1556703T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK03776874T 2002-10-22 2003-10-06 Inhibitorer af Src-kinase til anvendelse ved alzheimers sygdom DK1556703T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20020292608 EP1413887A1 (fr) 2002-10-22 2002-10-22 Inhibiteurs de Src kinase pour le traitement de la maladie d'Alzheimer
PCT/EP2003/012063 WO2004038422A2 (fr) 2002-10-22 2003-10-06 Inhibiteurs de la src kinase destines a etre utilises dans la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
DK1556703T3 true DK1556703T3 (da) 2009-02-23

Family

ID=32050112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03776874T DK1556703T3 (da) 2002-10-22 2003-10-06 Inhibitorer af Src-kinase til anvendelse ved alzheimers sygdom

Country Status (9)

Country Link
US (1) US20040176313A1 (fr)
EP (2) EP1413887A1 (fr)
JP (1) JP2006503570A (fr)
AT (1) ATE412186T1 (fr)
AU (1) AU2003286144A1 (fr)
DE (1) DE60324309D1 (fr)
DK (1) DK1556703T3 (fr)
ES (1) ES2314261T3 (fr)
WO (1) WO2004038422A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
US8618063B2 (en) * 2008-04-09 2013-12-31 The Board Of Trustees Of The University Of Illinois Method for treating a synucleinopathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1250155B1 (fr) * 1999-12-22 2008-04-16 The Scripps Research Institute Modulateurs et inhibiteurs de la permeabilite angiogenique et vasculaire
JP4317310B2 (ja) * 2000-03-09 2009-08-19 三菱化学株式会社 神経細胞死抑制作用を有する薬剤及びそのスクリーニング方法
JP2005512501A (ja) * 2000-12-06 2005-05-12 インサイト・ゲノミックス・インコーポレイテッド キナーゼおよびホスファターゼ
CA2491803A1 (fr) * 2002-06-25 2003-12-31 Serono Genetics Institute S.A. Polypeptides kcnq, modulateurs de ces polypeptides, et leurs utilisations dans le traitement de troubles mentaux
US7195884B2 (en) * 2002-07-19 2007-03-27 Promega Corp. Methods and kits for transferases

Also Published As

Publication number Publication date
EP1413887A1 (fr) 2004-04-28
WO2004038422A3 (fr) 2004-09-02
WO2004038422A2 (fr) 2004-05-06
DE60324309D1 (de) 2008-12-04
ES2314261T3 (es) 2009-03-16
JP2006503570A (ja) 2006-02-02
AU2003286144A1 (en) 2004-05-13
EP1556703A2 (fr) 2005-07-27
ATE412186T1 (de) 2008-11-15
US20040176313A1 (en) 2004-09-09
AU2003286144A8 (en) 2004-05-13
EP1556703B1 (fr) 2008-10-22

Similar Documents

Publication Publication Date Title
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
NO20060398L (no) Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
ATE493401T1 (de) Als proteinkinaseinhibitoren geeignete diaminotriazolverbindungen
NO20082311L (no) Terapeutisk middel for hjertesykdom
ATE420883T1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
WO2011046964A3 (fr) Inhibiteurs de tyrosine kinase de bruton
ATE473980T1 (de) Triazolopyridazine als proteinkinase-inhibitoren
ATE396731T1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
NO20045677L (no) Inhibitorer av JAK- og CDK2-proteinkinaser
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
NO20055496L (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
NZ713828A (en) Crystalline forms of a bruton’s tyrosine kinase inhibitor
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20070514L (no) Pyrrolotriazin kinase inhibitorer
ATE445398T1 (de) Kombinationen mit epothilonen und protein-tyrosin-kinasehemmern sowie pharamazeutische verwendung dafür
AU2003215586A1 (en) Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
WO2007075572A3 (fr) Inhibiteurs a base de purine oralement actifs de la proteine de choc thermique 90
DE60106409D1 (de) 3-aminopyrazole als inhibitoren von cyclinabhängigen kinasen
DK1556703T3 (da) Inhibitorer af Src-kinase til anvendelse ved alzheimers sygdom